Overt Bio

OverT Bio, founded in 2022 by Drs. Mat Legut and Neville Sanjana, is a biotechnology company based in New York, NY. The company specializes in developing innovative cell therapies aimed at identifying and curing hard-to-treat cancers. OverT Bio utilizes advanced pooled functional screening and synthetic genomics platforms, branded as OverTarget™, to drive its research and development. The company has secured $16 million in seed funding from notable investors such as ARTIS Ventures, Wing Venture Capital, and Alexandria Venture Investments.

Recent Posts by Overt Bio

1-1 of 1